Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: Systematic optimisation of the preparative process and preliminary biological evaluation

Pharmaceutical Research

Volumn 26, Issue 8, 2009, Pages 1918-1930

  Nasti, Alessandro ^a,b   Zaki, Noha M ^a,c   De Leonardis, Piero ^a   Ungphaiboon, Suwipa ^a   Sansongsak, Proramate ^a   Rimoli, Maria Grazia ^b   Tirelli, Nicola ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Ain Shams University   (Egypt)

Author keywords

Chitosan; Hyaluronic acid; Macrophages; Nanoparticles; Toxicity

Indexed keywords

CHITOSAN; HYALURONIC ACID; NANOCOATING; NANOPARTICLE;

ACIDITY; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CLINICAL EVALUATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; MACROPHAGE; MOLECULAR STABILITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESSING; ZETA POTENTIAL;

ANIMALS; CELL LINE; CHITOSAN; DRUG EVALUATION, PRECLINICAL; HYALURONIC ACID; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MICE; NANOPARTICLES;

EID: 67650065139     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9908-0     Document Type: Article

References (54)

1. N Tirelli 2006 (Bio)Responsive nanoparticles Pharmaceutical Research 11 210 216 10.1016/j.cocis.2006.09.002
2. A Rehor JA Hubbell N Tirelli 2005 Oxidation-sensitive polymeric nanoparticles Langmuir 21 411 417 10.1021/la0478043
3. L Brannon-Peppasand JO Blanchette 2004 Nanoparticle and targeted systems for cancer therapy Adv Drug Deliv Rev 56 1649 1659 10.1016/j.addr.2004.02.014
4. JK Oh R Drumright DJ Siegwart K Matyjaszewski 2008 The development of microgels/nanogels for drug delivery applications Prog Polym Sci 33 448 477 10.1016/j.progpolymsci.2008.01.002
5. S Ganta H Devalapally A Shahiwala M Amiji 2008 A review of stimuli-responsive nanocarriers for drug and gene delivery J Control Release 126 187 204 10.1016/j.jconrel.2007.12.017
6. VP Torchilin 2008 Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers Adv Drug Deliv Rev 60 548 558 10.1016/j.addr.2007. 10.008
7. D Peer JM Karp S Hong OC FaroKhzad R Margalit R Langer 2007 Nanocarriers as an emerging platform for cancer therapy Nature Nanotechnology 2 751 760 10.1038/nnano.2007.387
8. JK Vasirand V Labhasetwar 2007 Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv Drug Deliv Rev 59 718 728 10.1016/j.addr.2007.06. 003
9. LE van Vlerken TK Vyas MM Amiji 2007 Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery Pharm Res 24 1405 1414 10.1007/s11095-007-9284-6
10. M Goldberg R Langer XQ Jia 2007 Nanostructured materials for applications in drug delivery and tissue engineering J Biomater Sci Polym Ed 18 241 268 10.1163/156856207779996931
11. O Boussif F Lezoualch MA Zanta MD Mergny D Scherman B Demeneix 1995 A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo-polyethylenimine Proc Natl Acad Sci USA 92 7297 7301 10.1073/pnas.92.16.7297
12. YW Cho JD Kim K Park 2003 Pollycation gene delivery systems: escape from endosomes to cytosol J Pharm Pharmacol 55 721 734 10.1211/002235703765951311
13. N Murthy JR Robichaud DA Tirrell PS Stayton AS Hoffman 1999 The design and synthesis of polymers for eukaryotic membrane disruption J Control Release 61 137 143 10.1016/S0168-3659(99)00114-5
14. R Chen S Khormaee ME Eccleston NKH Slater 2009 The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides Biomaterials 30 1954 1961 10.1016/j.biomaterials. 2008.12.036
15. C Passirani G Barratt JP Devissaguet D Labarre 1998 Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) Pharm Res 15 1046 1050 10.1023/A:1011930127562
16. A Higuchi K Shirano M Harashima BO Yoon M Hara M Hattori 2002 Chemically modified polysulfone hollow fibers with vinylpyrrolidone having improved blood compatibility Biomaterials 23 2659 2666 10.1016/S0142-9612(01)00406-9
17. K Mequanint A Patel D Bezuidenhout 2006 Synthesis, swelling behavior, and biocompatibility of novel physically cross-linked polyurethane-block- poly(glycerol methacrylate) hydrogels Biomacromolecules 7 883 891 10.1021/bm0507047
18. JY Leeand AP Spicer 2000 Hyaluronan: a multifunctional, megaDalton, stealth molecule Curr Opin Cell Biol+ 12 581 586 10.1016/S0955-0674(00)00135-6
19. Y Zhang M Yang NG Portney D Cui G Budak E Ozbay 2008 Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells Biomed Microdevices 10 321 328 10.1007/s10544-007-9139-2
20. A Basarkar D Devineni R Palaniappan J Singh 2007 Preparation, characterization, cytotoxicity and transfection efficiency of poly(dl-lactide-co-glycolide) and poly(dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA Int J Pharm 343 247 254 10.1016/j.ijpharm.2007.05.023
21. A Rehor H Schmoekel N Tirelli JA Hubbell 2008 Functionalization of polysulfide nanoparticles and their performance as circulating carriers Biomaterials 29 1958 1966 10.1016/j.biomaterials.2007.12.035
22. O Etienne A Schneider C Taddei L Richert P Schaaf JC Voegel 2005 Degradability of polysaccharides multilayer films in the oral environment: an in vitro and in vivo study Biomacromolecules 6 726 733 10.1021/bm049425u
23. SA Agnihotri NN Mallikarjuna TM Aminabhavi 2004 Recent advances on chitosan-based micro- and nanoparticles in drug delivery J Control Release 100 5 28 10.1016/j.jconrel.2004.08.010
24. H Katasand HO Alpar 2006 Development and characterisation of chitosan nanoparticles for siRNA delivery J Control Releasee 115 216 225 10.1016/j.jconrel.2006.07.021
25. M Luangtana-anan P Opanasopit T Ngawhirunpat J Nunthanid P Sriamornsak S Limmatvapirat 2005 Effect of chitosan salts and molecular weight on a nanoparticulate carrier for therapeutic protein Pharm Dev Technol 10 189 196 10.1081/PDT-200054388
26. QY Deng CR Zhou BH Luo 2006 Preparation and characterization of chitosan nanoparticles containing lysozyme Pharm Biol 44 336 342 10.1080/ 13880200600746246
27. CR Dassand PFM Choong 2008 The use of chitosan formulations in cancer therapy J Microencapsul 25 275 279 10.1080/02652040801970461
28. M Van Beek L Jones H Sheardown 2008 Hyaluronic acid containing hydrogels for the reduction of protein adsorption Biomaterials 29 780 789 10.1016/j.biomaterials.2007.10.039
29. JA Johansson T Halthur M Herranen L Soderberg U Elofsson J Hilborn 2005 Build-up of collagen and hyaluronic acid polyelectrolyte multilayers Biomacromolecules 6 1353 1359 10.1021/bm0493741
30. TI Croll AJ O'Connor GW Stevens JJ Cooper-White 2006 A blank slate? Layer-by-layer deposition of hyaluronic acid and chitosan onto various surfaces Biomacromolecules 7 1610 1622 10.1021/bm060044l
31. L Richert P Lavalle E Payan XZ Shu GD Prestwich JF Stoltz 2004 Layer by layer buildup of polysaccharide films: Physical chemistry and cellular adhesion aspects Langmuir 20 448 458 10.1021/la035415n
32. P Calvo C RemunanLopez JL VilaJato MJ Alonso 1997 Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers J Appl Polym Sci 63 125 132 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 (Pubitemid 127613982)
33. KA Janesand MJ Alonso 2003 Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization J Appl Polym Sci 88 2769 2776 10.1002/app. 12016 (Pubitemid 36442069)
34. H Zhang M Oh C Allen E Kumacheva 2004 Monodisperse chitosan nanoparticles for mucosal drug delivery Biomacromolecules 5 2461 2468 10.1021/bm0496211
35. MR Kasaai J Arul C Charlet 2000 Intrinsic viscosity-molecular weight relationship for chitosan J Polym Sci B Polym Phys 38 2591 2598 10.1002/1099-0488(20001001)38:19<2591::AID-POLB110>3.0.CO;2-6
36. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 10.1016/0022-1759(83)90303-4 (Pubitemid 14203433)
37. R Zange Y Li T Kissel 1998 Biocompatibility testing of ABA triblock copolymers consisting of poly(-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture model J Control Release 56 249 258 10.1016/S0168-3659(98)00093-5
38. He X, Ma J, Mercado AE, Xu W, Jabbari E. Cytotoxicity of paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles. Pharm Res. 2008;25:1552-1562.
39. D Fischer Y Li B Ahlemeyer J Krieglstein T Kissel 2003 In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 1121 1131 10.1016/S0142-9612(02)00445-3
40. Z Zhang S Huey Lee SS Feng 2007 Folate-decorated poly(lactide-co- glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery Biomaterials 28 1889 1899 10.1016/j.biomaterials.2006.12.018
41. JL Alonso S Mascellaro Y Moreno MA Ferrus J Hernandez 2002 Double-staining method for differentiation of morphological changes and membrane integrity of Campylobacter coli cells Appl Environ Microbiol 68 5151 5154 10.1128/AEM.68.10.5151-5154.2002
42. FA Valea S Haskill DH Moore WC Fowler Jr 1995 Immunohistochemical analysis of alpha 1-integrins in cervical cancer Am J Obstet Gynecol 173 808 813 10.1016/0002-9378(95)90345-3
43. TR Green J Fisher M Stone BM Wroblewski E Ingham 1998 Polyethylene particles of a [']critical size' are necessary for the induction of cytokines by macrophages in vitro Biomaterials 19 2297 2302 10.1016/S0142-9612(98)00140-9 (Pubitemid 28550396)
44. V Olivier C Rivière M Hindié JL Duval G Bomila-Koradjim MD Nagel 2004 Uptake of polystyrene beads bearing functional groups by macrophages and fibroblasts Colloids Surf B Biointerfaces 33 23 31 10.1016/j.colsurfb.2003. 08.008
45. AS Zahr CA Davis MV Pishko 2006 Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol) Langmuir 22 8178 8185 10.1021/la060951b
46. Biological evaluation for medical devices-part 5: tests for cytotoxicity: in vitro methods. ISO 10993-5 (EN 30993-5), (1992).
47. MA Jepson 2005 Advances in fluorescence imaging: opportunities for pharmaceutical science Adv Drug Deliv Rev 57 1 4 10.1016/j.addr.2004.08.001
48. M Huang E Khor LY Lim 2004 Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation Pharm Res 21 344 353 10.1023/B:PHAM.0000016249.52831.a5
49. ZS Maand LY Lim 2003 Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles Pharm Res 20 1812 1819 10.1023/B:PHAM.0000003379.76417.3e
50. O Harush-Frenkel N Debotton S Benita Y Altschuler 2007 Targeting of nanoparticles to the clathrin-mediated endocytic pathway Biochem Biophys Res Commun 353 26 32 10.1016/j.bbrc.2006.11.135
51. M Ruponen P Honkakoski M Tammi A Urtti 2004 Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer J Gene Med 6 405 414 10.1002/jgm.522
52. C Lemarchand R Gref C Passirani E Garcion B Petri R Muller 2006 Influence of polysaccharide coating on the interactions of nanoparticles with biological systems Biomaterials 27 108 118 10.1016/j.biomaterials.2005.04.041
53. D Peerand R Margalit 2004 Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models Int J Cancer 108 780 789 10.1002/ijc.11615
54. C Lemarchand R Gref P Couvreur 2004 Polysaccharide-decorated nanoparticles Eur J Pharm Biopharm 58 327 341 10.1016/j.ejpb.2004.02.016